Modeling dopamine system dysfunction in experimental animals. (Q48323335)

10 February 2018

review article

1 reference

title

Modeling dopamine system dysfunction in experimental animals. (English)

1 reference

10 February 2018

author name string

Hantraye P

series ordinal

1

1 reference

10 February 2018

publication date

1 November 1998

1 reference

10 February 2018

Nuclear Medicine and Biology

published in

1 reference

10 February 2018

volume

25

1 reference

10 February 2018

issue

8

1 reference

10 February 2018

page(s)

721-728

1 reference

10 February 2018

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Cognitive function in Parkinson's disease: From description to theory

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Monkeys with unilateral ventromedial tegmental lesions of the brain stem: models for Parkinson's disease and Lesch-Nyhan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

The role of the subthalamic nucleus in experimental chorea. Evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Schizophrenia as a brain disease. The dopamine receptor story

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900054-7

7 January 2021

10.1016/S0969-8051(98)00054-7

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9863556

1 reference

10 February 2018